2018 ISPD Conference has ended

Create Your Own Event

2018 ISPD Conference

This program is subject to change. Speakers are added as confirmations are received.
Please note that preconference courses require separate registration.
Downloads: Oral Abstracts Poster Abstracts

09:00 CEST

Course 3 - Ultrasound and Genetic Syndromes Okapi Room 2&3

11:15 CEST

Course 3 - continued Okapi Room 2&3

14:00 CEST

Course 5 - Extending Prenatal Diagnosis of Monogenic Disorders: What we can do, what we will be able to do, dealing with the counseling challenges for implementation Okapi Room 2&3

16:15 CEST

Course 5 - continued Okapi Room 2&3

11:00 CEST

Oral Poster Presentations: Imaging/FMF Okapi Room 2&3

14:00 CEST

Session 1 | Fetal Therapy Invited Presentation: How to identify the fetus in need for fetal therapy Okapi Room 2&3

14:30 CEST

Session 1 | Fetal Therapy Invited Presentation: Maternal risks of fetal therapy Okapi Room 2&3

15:00 CEST

Session 1 | Fetal Therapy: 1-1 The combinative effect of testosterone treatment and the timing of diagnosis on neurocognitive abilities and ADHD in 47,XXY (Klinefelter Syndrome) Okapi Room 2&3

15:15 CEST

Session 1 | Fetal Therapy: 1-2 Neurodevelopmental effects of maternal uterine artery Ad.VEGF-A165 treatment for fetal growth restriction in fetal guinea pigs Okapi Room 2&3

15:30 CEST

Session 1 | Fetal Therapy: 1-3 Set up an amniotic fluid stem cell-derived induced pluripotent stem cells disease model and in utero therapy for spina bifida Okapi Room 2&3

15:45 CEST

Session 1 | Fetal Therapy: 1-4 Preliminary Results of a Long-Term Follow-Up Study in Spontaneous Twin Anemia-Polycythemia Sequence Okapi Room 2&3

10:30 CEST

Session 3 | Prenatal Counseling Invited Presentation: Educating professionals on delivering NIPT to meet patient needs Okapi Room 2&3

10:55 CEST

Session 3 | Prenatal Counseling Invited Presentation: Prenatal decision-making aids Okapi Room 2&3

11:20 CEST

Session 3 | Prenatal Counseling: 3-1 Assessment of Patient Understanding of Non-Invasive Prenatal Testing Following Introduction of Three Systematic Patient Counselling Models Okapi Room 2&3

11:34 CEST

Session 3 | Prenatal Counseling: 3-2 Use of a novel tablet-based decision aid for prenatal aneuploidy screening and testing: A randomized controlled trial Okapi Room 2&3

11:48 CEST

Session 3 | Prenatal Counseling: 3-3 Accessibility of conflict of interest disclosures for professional medical societies of relevance to the practice of prenatal diagnosis Okapi Room 2&3

10:45 CEST

Session 5 | Novel approaches to predict adverse fetal outcome Invited Presentation: Early prediction of adverse pregnancy outcomes Okapi Room 2&3

11:15 CEST

Session 5 | Novel approaches to predict adverse fetal outcome Invited Presentation: Novel approaches to investigation of fetal death: Still Birth Alliance Okapi Room 2&3

11:45 CEST

Session 5 | Novel approaches to predict adverse fetal outcome: 5-1 Predicting fetoplacental chromosomal mosaicism during non-invasive prenatal testing Okapi Room 2&3

12:00 CEST

Session 5 | Novel approaches to predict adverse fetal outcome: 5-2 Is cell-free DNA testing appropriate in fetuses with increased nuchal translucency? Okapi Room 2&3

12:15 CEST

Session 5 | Novel approaches to predict adverse fetal outcome: 5-3 Early delivery in fetal gastroschisis: A randomized controlled trial of elective 34 week delivery versus routine obstetrical care Okapi Room 2&3

12:30 CEST

Session 5 | Novel approaches to predict adverse fetal outcome: 5-4 ASPRE trial: incidence of preterm preeclampsia in patients fulfilling ACOG and NICE criteria according to risk by the FMF algorithm Okapi Room 2&3